ResMed Projected to Attain High-Single-Digit EPS Growth in Next Three Years, RBC Says
ResMed (RMD) is projected to attain high-single-digit EPS growth over the next three years, despite
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo